SCHEMBL7877609

SCHEMBL7877609

CCN(CC)Cc1cccc(Oc2ccc(Cl)c3cc(C(=O)N(C)C(=N)N)[nH]c23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
GRIN1 Q05586 2/20 0.34
DAGLA Q9Y4D2 1/20 0.33
ACHE P22303 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTR1A P08908 1/20 0.33
HTR2C P28335 1/20 0.33
HTR7 P34969 1/20 0.33
HTR2B P41595 1/20 0.33
HTR5A P47898 1/20 0.33
HTR6 P50406 1/20 0.33
BCHE P06276 1/20 0.33
GRIN2D O15399 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873728 0.92 SLC6A4 (0.41) HTR2ASLC6A4GRIN1DAGLAPPARG
SCHEMBL7877753 0.90 HTR2A (0.39) HTR2ASLC6A4ACHEHTR1AHTR2C
SCHEMBL7877435 0.89 F10 (0.40) HTR2ASLC6A4GRIN1DAGLAACHE
SCHEMBL7880193 0.89 SCN9A (0.36) ACHEDRD2DRD3TSHRHSD17B10
SCHEMBL7881402 0.88 HTR2A (0.35) HTR2ASLC6A4ACHEBRD4SCN9A
SCHEMBL7873837 0.88 NPC1 (0.38) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7879882 0.84 SYK (0.33) ACHEHTR1AHTR2CHTR7HTR2B
SCHEMBL7873652 0.84 HTR2A (0.33) HTR2ASLC6A4BRD4
SCHEMBL7884844 0.84 RHEB (0.35) HTR2ASLC6A4BRD4RHEBFBP1
SCHEMBL7881958 0.84 PPARG (0.38) GRIN1DAGLAACHEPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed